Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance
Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance
Recruiting · NCT06747507 · Registry updated 2025-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance | HIV-1-infection | Recruiting | Phase 3 | 2025-09-11 | NCT06747507 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bomu Hospital | Mombasa | Kenya | 2 |
| Butha-Buthe District Hospital | Butha-Buthe | Lesotho | 2 |
| CS Machava II | Maputo | Mozambique | 2 |
| CS Ndlavela | Maputo | Mozambique | 2 |
| CS Ponta Gea | Beira | Mozambique | 2 |
| Jaramogi Oginga Odinga Teaching and Referral Hospital | Kisumu | Kenya | 3 |
| Kenyatta National Hospital | Nairobi | Kenya | 2 |
| Mokhotlong District Hospital | Mokhotlong | Lesotho | 2 |
| MUHAS Clinical Trial Unit | Dar es Salaam | Tanzania | 2 |